PTIX Protagenic Therapeutics, Inc.
-
Protagenic Therapeutics Reported Earnings
Wednesday, August 19, 2026 · 12:00 AM ET
Protagenic Therapeutics (PTIX) reported a loss of $0.53 per share on revenue of $0.00 million for the . .
Protagenic Therapeutics, Inc. is a biotechnology company. It focused on the discovery, research and development of novel and naturally occurring human brain hormones for the treatment of anxiety and depression based mood disorders. Protagenic Therapeutics, Inc., formerly known as Atrinsic, Inc., is based in New York, United States.
Earnings Whisper Grade
—
Power Rating—
Reported Earnings
($0.53)
Earnings Whisper®
—
Consensus Estimate
—
Earnings Surprise
Earnings Growth
Reported Revenue
—
Revenue Estimate
—
Revenue Surprise
Revenue Growth—